Prof. Scheinert serves as Principal Investigator of the RANGER-SFA trial. The first-in-human RANGER-SFA trial is a multicenter randomized controlled trial evaluating the Ranger paclitaxel-coated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback